Histone deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation and stabilization of Snail to promote metastasis of hepatoma cells
- PMID: 29410023
- DOI: 10.1016/j.canlet.2018.01.068
Histone deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation and stabilization of Snail to promote metastasis of hepatoma cells
Abstract
Hepatocellular carcinoma (HCC) remains the third most common cause of cancer-related mortality. Resection and transplantation are the only curative treatments available, but are greatly hampered by high recurrence rates. Histone deacetylase inhibitors (HDACIs) are considered to be promising anticancer agents in drug development. Currently, four HDACIs have been granted Food and Drug Administration (FDA) approval for cancer. HDACIs have shown significant efficacy in hematological malignancies. However, they have limited effects in epithelial cell-derived cancers, including HCC, and the mechanisms of these are not elucidated. In this study, our results demonstrated that HDACIs were able to induce epithelial-mesenchymal transitions (EMT) in hepatoma cells which are believed to trigger tumor cell invasion and metastasis. We found that HDACIs promoted the expression of Snail and Snail-induced EMT was critical for HDACI-initiated invasion and metastasis. We indicated that HDACIs upregulated Snail in two ways. Firstly, HDACIs upregulated Snail at the transcriptional level by promoting Smad2/3 phosphorylation and nuclear translocation, then combined with the promoter to activate the transcription of Snail. Secondly, we showed that HDACIs regulated the stabilization of Snail via upregulating the expression of COP9 signalosome 2 (CSN2), which combined with Snail and exposed its acetylation site, then promoted acetylation of Snail, thereby inhibiting its phosphorylation and ubiquitination to repress the degradation of Snail. All these results highlighted that HDACIs have limited effects in HCC, and the use of HDACIs combined with other targeted strategies to inhibit EMT, which explored in this study is a promising treatment method for treating HCC.
Keywords: Epithelial-mesenchymal transitions; Histone deacetylase inhibitors; Snail stabilization; Transcriptional activation; Tumor metastasis.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression.Biochim Biophys Acta. 2013 Mar;1833(3):663-71. doi: 10.1016/j.bbamcr.2012.12.002. Epub 2012 Dec 12. Biochim Biophys Acta. 2013. PMID: 23246564
-
Post-transcription mediated Snail stabilization is involved in radiation exposure induced invasion and migration of hepatocarcinoma cells.Biomed Pharmacother. 2018 Jul;103:767-772. doi: 10.1016/j.biopha.2018.04.095. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29684855
-
RMP promotes epithelial-mesenchymal transition through NF-κB/CSN2/Snail pathway in hepatocellular carcinoma.Oncotarget. 2017 Jun 20;8(25):40373-40388. doi: 10.18632/oncotarget.16177. Oncotarget. 2017. PMID: 28423737 Free PMC article.
-
Epigenetic Regulation and Post-Translational Modifications of SNAI1 in Cancer Metastasis.Int J Mol Sci. 2021 Oct 14;22(20):11062. doi: 10.3390/ijms222011062. Int J Mol Sci. 2021. PMID: 34681726 Free PMC article. Review.
-
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells.Antioxid Redox Signal. 2015 Jul 1;23(1):66-84. doi: 10.1089/ars.2014.5863. Epub 2014 Mar 27. Antioxid Redox Signal. 2015. PMID: 24512308 Free PMC article. Review.
Cited by
-
Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma.Cancer Manag Res. 2019 Oct 16;11:8947-8963. doi: 10.2147/CMAR.S225606. eCollection 2019. Cancer Manag Res. 2019. PMID: 31802937 Free PMC article. Review.
-
Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.Mol Cancer. 2019 May 24;18(1):101. doi: 10.1186/s12943-019-1030-2. Mol Cancer. 2019. PMID: 31126310 Free PMC article. Review.
-
Snail1: A Transcriptional Factor Controlled at Multiple Levels.J Clin Med. 2019 May 28;8(6):757. doi: 10.3390/jcm8060757. J Clin Med. 2019. PMID: 31141910 Free PMC article. Review.
-
Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer.Cell Oncol (Dordr). 2024 Sep 16. doi: 10.1007/s13402-024-00989-9. Online ahead of print. Cell Oncol (Dordr). 2024. PMID: 39283477
-
UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin.Front Oncol. 2023 Mar 9;13:1088475. doi: 10.3389/fonc.2023.1088475. eCollection 2023. Front Oncol. 2023. PMID: 36969045 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials